Clinical Trials Directory

Trials / Completed

CompletedNCT02482675

Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Milk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Ohio State University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function and increase the risk of CVD. Greater intakes of dairy foods have been associated with a lower risk of CVD, but whether these effects occur directly or indirectly by displacing foods in the diet that might increase CVD risk is unclear. The health benefits of dairy on heart health are at least partly attributed to its ability to limit PPH and resulting PPH-mediated responses leading to vascular dysfunction. This provides rationale to further investigate dairy as a dietary strategy to reduce PPH and risk for CVD. The objective of this study is to define the extent to which dairy milk, and its whey and casein protein fractions, protect against postprandial vascular dysfunction by reducing oxidative stress responses that limit nitric oxide bioavailability to the vascular endothelium in adults with prediabetes.

Detailed description

This study consists of four, 3-hour postprandial trials in response to consuming the following dietary treatments: 1. oral glucose challenge, 2. oral glucose challenge in combination with non-fat milk, 3. oral glucose challenge in combination with whey protein isolate, and 4. oral glucose challenge in combination with sodium caseinate. For three days preceding each trial, participants will be provided all meals to standardize physiologic responses to test meals. On each trial day, vascular function will be assessed and blood samples collected prior to and at 30 minute intervals for 3 hours following test meal ingestion.

Conditions

Interventions

TypeNameDescription
OTHERGlucoseFollowing baseline measurements, participants will consume a 75 g glucose solution within five minutes.
OTHERGlucose with Non-fat MilkFollowing baseline measurements, participants will consume 75 g glucose dissolved in two cups of non-fat milk within five minutes.
OTHERGlucose with Whey Protein IsolateFollowing baseline measurements, participants will consume 75 g glucose and whey protein isolate dissolved in 2 cups water within five minutes.
OTHERGlucose with Sodium CaseinateFollowing baseline measurements, participants will consume 75 g glucose and sodium caseinate dissolved in 2 cups water within five minutes.

Timeline

Start date
2015-06-01
Primary completion
2016-07-01
Completion
2018-02-01
First posted
2015-06-26
Last updated
2019-05-14
Results posted
2019-05-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02482675. Inclusion in this directory is not an endorsement.